Stock 300111 ZHEJIANG SUNFLOWER GREAT HEALTH CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Zhejiang Sunflower Great Health Co., Ltd.

Equities

300111

CNE100000SX9

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 23:00:00 05/05/2024 BST 		5-day change 1st Jan Change
2.45 CNY +2.51% Intraday chart for Zhejiang Sunflower Great Health Co., Ltd. +7.46% -19.41%
04-26 Zhejiang Sunflower Great Health Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-23 Zhejiang Sunflower Great Health Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Business Summary

Zhejiang Sunflower Great Health Co Ltd, formerly Zhejiang Sunflower Great Health LLC, is a China-based company principally engaged in pharmaceutical manufacturing. The Company's main business is the research and development, production, and sales of anti infective, cardiovascular, and digestive system drugs. The Company's main products include clarithromycin raw materials, clarithromycin tablets, azithromycin dispersible tablets, azithromycin for injection, and erythromycin capsules. The Company's products are mainly used to treat infectious diseases, cardiovascular diseases, and digestive system diseases. The Company mainly conducts its business in domestic and overseas markets.

Number of employees: 319

Sales per Business

CNY in Million2021Weight2022Weight Delta
Raw Material
58.9 %
140 47.0 % 198 58.9 % +41.60%
Pharmaceutical
40.1 %
154 51.9 % 135 40.1 % -12.67%
Others
1.0 %
2 0.6 % 3 1.0 % +86.59%

Sales per region

CNY in Million2021Weight2022Weight Delta
China
75.8 %
250 84.0 % 255 75.8 % +1.92%
Foreign
24.2 %
47 16.0 % 81 24.2 % +71.12%

Managers

Managers TitleAgeSince
Hua Xin Shi CEO
 Chief Executive Officer 56 18/10/16
Wei Biao Pan DFI
 Director of Finance/CFO 54 07/07/19
Lan Li SEC
 Corporate Secretary 41 18/06/15

Members of the board

Members of the board TitleAgeSince
Feng Wu BRD
 Director/Board Member 47 02/04/15
Lan Li SEC
 Corporate Secretary 41 18/06/15
Yang Cao CHM
 Chairman 51 14/11/19
Shu Qin Chen BRD
 Director/Board Member 64 15/08/21
Hua Xin Shi CEO
 Chief Executive Officer 56 18/10/16
Guo Hua Liu BRD
 Director/Board Member 62 23/08/18
Wei Biao Pan DFI
 Director of Finance/CFO 54 07/07/19
Qiong Wu CHM
 Chairman 34 03/03/20
Zhi Han Lin BRD
 Director/Board Member 33 10/02/20
Dong Zhe Sun BRD
 Director/Board Member 46 10/09/23

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 1,287,210,714 303,747,279 ( 23.60 %) 0 23.60 %

Shareholders

NameEquities%Valuation
Jian Long Wu
19.51 %
218,498,417 19.51 % 76 M ¥
Gfund Management Co., Ltd.
0.0968 %
1,084,500 0.0968 % 376 636 ¥
HFT Investment Management Co., Ltd.
0.007019 %
78,600 0.007019 % 27 297 ¥
NameEquities%Valuation
Jian Long Wu
100.00 %
167,410,714 100.00 % 58 M ¥

Company contact information

Zhejiang Sunflower Great Health Co., Ltd.

Sanjiang Road Shaoxing Paojiang Industrial Zone

312071, Shaoxing

+

http://www.sunowe.com
address Zhejiang Sunflower Great Health Co., Ltd.(300111)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Sector Other Pharmaceuticals

1st Jan change Capi.
ZHEJIANG SUNFLOWER GREAT HEALTH CO., LTD. Stock Zhejiang Sunflower Great Health Co., Ltd.
-19.41% 425M
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+28.50% 662B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+22.23% 546B
JOHNSON & JOHNSON Stock Johnson & Johnson
-4.93% 359B
MERCK & CO., INC. Stock Merck & Co., Inc.
+16.97% 323B
ABBVIE INC. Stock AbbVie Inc.
+4.08% 289B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.68% 234B
NOVARTIS AG Stock Novartis AG
+3.84% 198B
ROCHE HOLDING AG Stock Roche Holding AG
-10.35% 194B
AMGEN INC. Stock Amgen Inc.
+3.98% 167B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 300111 Stock
  4. Company Zhejiang Sunflower Great Health Co., Ltd.